Method for isolating target nucleic acid using heteroduplex binding proteins

Patent metadata

Field	Value
Publication number	US-11898196-B2
Application number	US-202117405083-A
Country	US
Kind code	B2
Filing date	Aug 18, 2021
Priority date	May 20, 2015
Publication date	Feb 13, 2024
Grant date	Feb 13, 2024

Abstract

The invention includes methods and apparatus for separating mutations, especially rare and unknown mutations, using heteroduplex binding proteins. Nucleic acids may optionally be nicked at or near the mutation in order to promote heteroduplex binding protein recognition and binding. In particular, using the disclosed methods, it is possible to separate heteroduplexed nucleic acid strand pair from homoduplexed nucleic acid strand pairs having similar sequences and being at a much higher concentration. Once the heteroduplexed nucleic acids are isolated and recovered, it is straightforward to analyze the sequences of the heteroduplexed nucleic acids, e.g., using sequencing or hybrid assays.

First claim

What is claimed is:

1. A method for separating target heteroduplex nucleic acid from background nucleic acid, comprising;
nicking the target heteroduplex nucleic acid;
loading a mixture of nicked target heteroduplex nucleic acid and background homoduplex nucleic acid on a separation medium, wherein the target heteroduplex nucleic acid and the background homoduplex nucleic acid differ by at least one base;
contacting the mixture of target heteroduplex nucleic acid and background homoduplex nucleic acid with a heteroduplex-binding protein to create a heteroduplex-binding protein-nucleic acid mixture;
applying a time-varying driving field to the separation medium; and
applying a time-varying mobility varying field to the separation medium,
thereby causing the target heteroduplex nucleic acid to be separated from the background homoduplex nucleic acid.

2. The method of claim 1 , wherein the separation medium comprises the heteroduplex binding protein.

3. The method of claim 1 , wherein the heteroduplex-binding protein comprises a mismatch recognition domain.

4. The method of claim 1 , wherein the heteroduplex-binding protein is MutS or a modified MutS protein.

5. The method of claim 1 , wherein the amino acid sequence of the heteroduplex-binding protein is at least 85% identical to SEQ ID NO.1, SEQ ID NO. 2, or SEQ ID NO. 3.

6. The method of claim 1 , further comprising denaturing the heteroduplex-binding protein.

7. The method of claim 1 , wherein the time-varying driving field comprises two or three non-collinear electric fields.

8. The method of claim 1 , further comprising sequencing the target heteroduplex nucleic acid.

9. The method of claim 1 , wherein the background nucleic acid comprises wild-type nucleic acid and the target nucleic acid comprises a mutation.

10. The method of claim 1 , further comprising:
obtaining a sample comprising nucleic acid;
denaturing the nucleic acid to produce single-stranded nucleic acid; and
reannealing the single-stranded nucleic acid with reference to nucleic acids to create the mixture of target heteroduplex nucleic acid and background homoduplex nucleic acid.

11. The method of claim 10 , further comprising amplifying the single-stranded nucleic acid.

12. The method of claim 11 , further comprising adding an adapter sequence or a barcode sequence to the target heteroduplex nucleic acid and background homoduplex nucleic acid.

13. The method of claim 1 , wherein the target heteroduplex nucleic acid to background homoduplex nucleic acid ratio is from 1:1 to 1:1,000,000.

14. The method of claim 1 , wherein the target heteroduplex nucleic acid and homoduplex background nucleic acid are recovered from a biological sample, wherein the sample is selected from whole blood, serum, plasma, sputum, tissue, sweat, tears, urine, or aspirate.

15. The method of claim 14 , further comprising identifying a ratio of target heteroduplex nucleic acid to background homoduplex nucleic acid in the sample.

16. The method of claim 1 , further comprising nicking and then ligating the homoduplex nucleic acid.

Assignees

• Quantum Si Inc

Inventors

• Marziali Andrea
• Despotovic Milenko
• Wiggin Matthew
• Pel Joel

Classifications

• C12Q1/6811 Primary

  Selection methods for production or design of target specific oligonucleotides or binding molecules · CPC title

• C12Q1/6806 Primary

  Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay (C12Q1/6804 takes precedence) · CPC title

• C12Q1/686

  Polymerase chain reaction [PCR] · CPC title

• C12Q1/6869

  Methods for sequencing · CPC title

• C12Q1/6874

  involving nucleic acid arrays, e.g. sequencing by hybridisation · CPC title